QTRX — Quanterix Corp

—
Nasdaq · Unknown · Unknown · CIK 1503274 ·
Last close
$2.86
Market Cap
$135.79M
52W High
$8.77
52W Low
$2.15
ADV30
487,788
Next earnings
2026-11-09
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, the company offers contract research and clinical laboratory testing services, including research and clinical trial testing, and lucent diagnostic services. The company primarily operates in the areas of neurology, oncology and immunology, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and sales force and distributors. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 34,974,000 13,500,000 -22,325,000 -21,591,000 300,437,000 35,864,000 81,087,000
Jun 2026 32,906,000 12,674,000 -22,497,000 -48,934,000 319,627,000 44,169,000 82,415,000
Mar 2026 36,415,000 15,566,000 -21,527,000 -17,541,000 366,672,000 36,182,000 84,533,000
Dec 2025 43,777,000 19,960,000 -23,868,000 -23,117,000 418,766,000 29,839,000 123,036,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-55,872,000
Investing CF
$55,267,000
Financing CF
$-1,767,000
CapEx
$-935,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.36
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-643,706,000
Inventory
$47,601,000
Receivables
$22,345,000
ST Investments
$49,360,000
EBIT TTM
$-98,043,000
Pretax Income TTM
$-125,305,000
Interest Exp TTM
—
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$148,150,000
EBITDA
$-56,180,000
Free Cash Flow
$-12,487,375
Enterprise Value
$93,114,776
Total Cash
$77,359,000
Total Debt
$31,362,000
Shares Out
47,478,422
Trailing EPS
$-2.34
Book Value
$4.62
ROE
-41.7%
ROA
-13.3%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 138,654,000 -109,815,000 -107,150,000 418,766,000 123,036,000 295,730,000 -77,236,000
Dec 2024 135,436,000 -52,616,000 -38,531,000 406,533,000 76,495,000 330,038,000 -35,164,000
Dec 2023 121,139,000 -44,663,000 -28,354,000 428,567,000 78,609,000 349,958,000 -18,849,000
Dec 2022 104,952,000 -74,708,000 -99,574,000 433,582,000 75,650,000 357,932,000 -48,611,000

TTM Snapshot

Revenues TTM
$153,409,000
NetIncome TTM
$-123,108,000
OpCashFlow TTM
—
Assets (Latest)
$319,627,000
Forward EPS
$-1.36

Max Pain — expiry 2027-02-19 (volume-derived — Yahoo OI feed degraded)

max pain strike: $2.50 · spot: $2.07 · call volume: 110 · put volume: 40
Expected Move to 2027-02-19: ±$1.55 (74.88%) — implied range $0.52 – $3.62 · ATM straddle on $2.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
MHF WESTERN ASSET MUNICIPAL HIGH INCOME FUND INC. $135.34M $6.09 —
CGNRF Copper Giant Resources Corp. $136.25M $0.52 —
WRLGF West Red Lake Gold Mines Ltd. $135.04M $0.33 —
BMN BlackRock 2037 Municipal Target Term Trust $136.54M $22.21 —
BGX Blackstone Long-Short Credit Income Fund $134.96M $10.62 —

News headlines (Yahoo Finance, 1h cache)

Quanterix Announces Leadership Transition Plan
2026-11-18 13:03 · Yahoo
GeneDx Announces Leadership Transition
2026-11-18 13:00 · Yahoo
Mammogen Launches Leadership Council to Unite Industry Experts and Survivors, Names Former Quest Diagnostics CMO Dr. Yuri Fesko as Founding Member
2026-11-17 12:02 · Yahoo
Quanterix Expands Access to Blood-Based Alzheimer's Testing in New Jersey and Surrounding Area Through Exclusive Partnership with Sherman Abrams Laboratory
2026-11-16 18:30 · Yahoo
ALZAI Health Corp. Enters into MOU with Quanterix Corporation to Advance Early Alzheimer's Disease Identification
2026-11-13 11:00 · Yahoo
Quanterix Corp (QTRX) Q3 2026 Earnings Call Highlights: Sequential Growth and Strategic ...
2026-11-12 23:01 · Yahoo
Quanterix Corp (QTRX) Q3 2026 Earnings Call Transcript
2026-11-09 18:13 · Yahoo
Quanterix Corporation Q3 2026 Earnings Call Summary
2026-11-09 17:53 · Yahoo
What Quanterix (QTRX) Said on Its Q3 Earnings Call
2026-11-09 16:15 · Yahoo
Quanterix Releases Financial Results for the Third Quarter of 2026
2026-11-09 13:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.